Related Experiment Video
Updated: Feb 14, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
The cholinergic anti-inflammatory pathway revisited.
1Department of Anatomy, Physiology, and Cell Biology, UC Davis School of Veterinary Medicine, UC Davis, Davis, CA, USA.
Neural stimulation offers a promising approach to treat inflammatory bowel disease by modulating immune responses. Research explores the cholinergic anti-inflammatory pathway and its neural circuits for targeted immune cell regulation.
Area of Science:
- Neurogastroenterology
- Immunology
- Inflammatory Bowel Disease
Background:
- Inflammatory bowel disease (IBD) significantly impacts patient quality of life, with aberrant immune activation as a key factor.
- Current treatments aim for selective immune modulation, avoiding broad immunosuppression.
- The cholinergic anti-inflammatory pathway, involving vagal nerve signaling, is a focus for immune regulation.
Purpose of the Study:
- To investigate the neural circuitry and mechanisms underlying immune regulation, specifically concerning the vagus nerve's role in intestinal inflammation.
- To address controversies regarding the neuroanatomical connections and the efficacy of vagal nerve stimulation in IBD.
Main Methods:
- The study by Willemze et al. experimentally characterizes neural pathways involved in immune regulation.
- Focuses on efferent vagal nerve signaling and its impact on inflammatory processes.
- Considers the role of sympathetic innervation and alternative neural circuits.
Main Results:
- Findings contribute to understanding the neural control of immune responses in the context of IBD.
- Highlights ongoing debates regarding the precise neural mechanisms of vagal nerve stimulation.
- Suggests potential involvement of sympathetic pathways in immune regulation.
Conclusions:
- Further research into these neural pathways is crucial for developing novel neurostimulator-based therapies for IBD.
- Clarifying the neural circuitry will enhance the efficacy and specificity of neuromodulation treatments for inflammatory conditions.
More Related Videos
06:43Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Related Concept Videos
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Cholinergic Neurons: Neurotransmission
Cholinergic Receptors: Muscarinic
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Cholinergic Antagonists: Pharmacokinetics